Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurford Capital Regulatory News (BUR)

Share Price Information for Burford Capital (BUR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,210.00
Bid: 1,209.00
Ask: 1,211.00
Change: -17.00 (-1.39%)
Spread: 2.00 (0.165%)
Open: 1,250.00
High: 1,250.00
Low: 1,209.00
Prev. Close: 1,227.00
BUR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results for six months ended 30 June 2020

1 Oct 2020 07:00

RNS Number : 6973A
Burford Capital Limited
01 October 2020
 

 

This announcement contains inside information.

 

1 October 2020

 

 

BURFORD CAPITAL REPORTS SIGNIFICANT FIRST HALF 2020 REALISATIONS AND CASH RECEIPTS

 

Burford Capital Limited ("Burford Capital" or "Burford" or "the Company"), the leading global finance and asset management firm focused on law, today announces its financial results for the six-month period ended 30 June 2020 ("1H 2020").

 

Highlights1

 

· Burford-only realisations up 40% to $478 million (1H 2019: $342 million); Group-wide realisations up 32% to $820 million (1H 2019: $623 million)

 

· Robust Burford-only cash generation: $486 million in cash and net receivables generated in the period, 35% above 1H 2019 ($359 million)

o Cash flow positive in the period; cash receipts more than covered all operating expenses, finance costs and new deployments

 

· Strong cash position: $262 million in cash on Burford's balance sheet and a further $281 million in receivables at period end; at 15 September 2020, $86 million of those receivables had converted to cash, with cash balance rising to $316 million

 

· Burford-only realised gains from capital provision-direct assets up 57% at $183 million, representing 93% of adjusted profit before tax (1H 2019: 50%)

o No contribution from YPF-related assets to realised gains in this period (1H 2019: $98 million), showing the capacity of the broader portfolio to generate attractive profits

 

· 24% growth in cumulative recoveries from capital provision-direct assets on Burford's balance sheet to $1.6 billion drove an increase in capital provision-direct return on invested capital by 9 percentage points to 97% (31-Dec-19: 88%), generating an IRR of 32% (31-Dec-19: 31%)

o Demonstrating Burford's continuing ability to generate outsized returns from a portion of its assets, one group of 10 related assets realised during 1H 2020 fuelled the acceleration of returns, accounting for $266 million of Burford-only recoveries, $172 million of realised gains, an ROIC of 182% and an IRR of 49% for Burford's balance sheet

 

· COVID-19 lockdown impacted new business in the period, with Group-wide commitments down 74% to $195 million and deployments 42% lower at $258 million

o Litigation environment has stabilised and pipeline is rebuilding; also expect significant volume of disputes arising from pandemic in the years to come

 

· Burford-only total income amounted to $253 million, a decrease of 12%, though the mix of total income was more favourable than in 1H 2019

o No income from YPF-related assets in 1H 2020 compared to $188 million in 1H 2019

o Realised gains from non-YPF-related assets of $186 million in 1H 2020, up 49% over 1H 2019 ($125 million)

o Unrealised gains (net of transfers) from non-YPF-related assets of $65 million, up 30% (1H 2019: $50 million)

 

· As a result of holding adjusted operating expenses to a modest 4% increase, Burford-only adjusted operating profit was only down 14% to $218 million (1H 2019: $253 million) for an operating margin of 86%

 

· Burford-only adjusted profit after tax totalled $161 million (1H 2019: $227 million), reflecting a higher accounting tax expense of $36 million, though cash taxes were only $2 million

 

1 Figures for total income, operating profit, profit before tax and profit after tax in this release exclude the impact of amortisation of the intangible asset, operating expenses incurred related to (i) one-time expenses related to equity and listing matters and (ii) case-related legal fees not included in asset cost under IFRS, and third-party interests in consolidated entities, and are shown to assist understanding of the underlying performance of the Company.

 

 

Sir Peter Middleton, Chairman of Burford, commented:

 

"For the first time since Burford's launch in October 2009, the business was tested in the first half of 2020 by a historic global economic downturn. These financial results show that Burford passed this test with flying colours, recovering $820 million from concluded assets, significantly increasing cash and further strengthening liquidity. These outcomes do two things. First, they demonstrate the capacity of the portfolio to generate attractive cash profits. Second, they end any question about Burford being able to repeat the selection and management of outperforming matters. We look forward to implementing the Company's plans to list on the New York Stock Exchange alongside its UK listing."

 

Christopher Bogart, Chief Executive Officer of Burford, added:

 

"Burford achieved a very strong performance in the first half, with some substantial portfolio matters producing significant profits to drive an increase in cash on the balance sheet to $316 million by 15 September. In particular, Burford's most concentrated position was successful, generating $172 million of income and a 182% return on invested capital, with the result that our cumulative returns rose to a 97% ROIC and a 32% IRR. Unsurprisingly, in a world buffeted by COVID-19 and its ensuing consequences, while our team and operations have been largely unaffected, new business declined. Looking ahead, we see significant opportunity as the sizeable investments we have made have begun to come to fruition and as the economic downturn causes a significant increase in disputes."

 

 

Financial Summary

 

A financial summary of Burford's results is set out below. As usual, this summary is presented without third-party interests in Burford's consolidated entities and after certain adjustments to assist in understanding the underlying performance of the Company. Burford's complete interim report and accounts are available at http://www.rns-pdf.londonstockexchange.com/rns/6973A_1-2020-9-30.pdf or from the Burford website: www.burfordcapital.com/shareholders.

 

 

 

6 months ended 30 June 2020

 

6 months ended 30 June 2019

% change

 

 

$'000

 

$'000

 

 

 

 

 

 

 

Capital provision income

 

251,127

 

268,117

 

Asset management income

 

7,629

 

11,335

 

Services and other income

 

(5,906)

 

7,591

 

 

 

 

 

 

 

Total income*

 

 252,850

 

287,043

-12%

 

 

 

 

 

 

Operating expenses

 

(35,202)

 

(33,976)

 

 

 

 

 

 

 

Operating profit*

 

217,648

 

253,067

-14%

 

 

 

 

 

 

Finance costs

 

 (19,766)

 

(19,733)

 

 

 

 

 

 

 

Profit before tax*

 

197,882

 

233,334

-15%

 

 

 

 

 

 

Taxation

 

 (36,422)

 

(6,237)

 

 

 

 

 

 

 

Profit after tax*

 

161,460

 

227,097

-29%

 

 

 

 

 

 

* Total income, operating profit, profit before tax and profit after tax exclude the impact of amortisation of the intangible asset, operating expenses incurred related to (i) one-time expenses related to equity and listing matters and (ii) case-related legal fees not included in asset cost, and third-party interests in consolidated entities.

 

Investor and Analyst Conference Call

 

Burford will host a conference call for investors and analysts at 2.00pm (British Summer Time) / 9.00am (Eastern Daylight Time) on Thursday 1 October 2020.

 

Burford encourages investors and analysts to pre-register for dedicated audio webcast access via:

https://www.investis-live.com/burfordcapital/5f60779e17395d100039b233/remm.

 

The dial-in number for the conference call is +44 (0)20 3936 2999 (UK local) / +1 646 664 1960 (US local) / +44 (0)20 3936 2999 (all other locations) and the access code is 395796

 

An accompanying presentation will be available on the Burford Capital website: http://www.burfordcapital.com/shareholders.

 

A replay facility will be available until Thursday 15 October 2020 by dialling +44 (0)20 3936 3001 (UK local) / +1 845 709 8569 (US local) / +44 (0)20 3936 2999 (all other locations) and using the replay access code 398685.

 

This communication shall not constitute an offer to sell or the solicitation of an offer to buy any ordinary shares or other securities of Burford.

 

 

For further information, please contact:

 

Burford Capital Limited

 

Jim Kilman, Chief Financial Officer

+1 917 985 9840

Robert Bailhache, Head of Investor Relations, EMEA and Asia - email

+44 (0)20 3530 2023

Jim Ballan, Head of Investor Relations, Americas - email

+1 (646) 793 9176

 

 

Numis Securities Limited - NOMAD and Joint Broker

+44 (0)20 7260 1000

Huw Jeremy (NOMAD)

 

Charlie Farquhar / Jonathan Abbott (Joint Broker)

 

 

 

Jefferies International Limited - Joint Broker

+44 (0)20 7029 8000

Graham Davidson

 

Tony White

 

 

 

 

About Burford Capital

Burford Capital is the leading global finance and asset management firm focused on law. Its businesses include litigation finance and risk management, asset recovery and a wide range of legal finance and advisory activities. Burford is publicly traded on the London Stock Exchange, and it works with law firms and clients around the world from its principal offices in New York, London, Chicago, Washington, Singapore and Sydney.

 

For more information about Burford: www.burfordcapital.com

 

 

This release does not constitute an offer of any Burford fund. Burford Capital Investment Management LLC ("BCIM"), which acts as the fund manager of all Burford funds, is registered as an investment adviser with the U.S. Securities and Exchange Commission. The information provided herein is for informational purposes only. Past performance is not indicative of future results. The information contained herein is not, and should not be construed as, an offer to sell or the solicitation of an offer to buy any securities (including, without limitation, interests or shares in the funds). Any such offer or solicitation may be made only by means of a final confidential Private Placement Memorandum and other offering documents.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR WPUGABUPUPWU
Date   Source Headline
16th Apr 20243:30 pmRNSHolding(s) in Company
10th Apr 202412:00 pmRNSNotice of Retail Shareholder Call on June 20, 2024
10th Apr 202412:00 pmRNSIssuance of New Shares in Connection With LTIP
10th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholdings & Ownership Update
28th Mar 202411:00 amRNSAvailability of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20244:45 pmRNSNotification of Transactions by PDMRs
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20244:00 pmRNSIntended Purchases of Ordinary Shares
14th Mar 202411:00 amRNSAnnual results for year ended December 31, 2023
7th Mar 20245:30 pmRNSHolding(s) in Company
7th Mar 20242:00 pmRNSNotice of 2023 Results & Results Call Details
30th Jan 20244:15 pmRNSClosing of Private Offering of Senior Notes
18th Jan 202412:00 pmRNSPamela Corrie Appointed as Board Director
17th Jan 20247:00 amRNSPricing and Upsizing of Senior Notes Offering
16th Jan 202412:45 pmRNSPrivate Offering of Senior Notes
3rd Jan 202412:00 pmRNSIssuance of New Shares in Connection with LTIP
22nd Nov 202312:00 pmRNSDirector/PDMR Shareholding
16th Nov 202312:00 pmRNSSterling Conversion Rate for 2023 Interim Dividend
9th Nov 202312:00 pmRNS3Q23 Results & Quarterly Report
3rd Nov 20237:05 amRNSNotice of 3Q23 Results & Results Call Details
9th Oct 202312:00 pmRNSIssuance of New Shares in Connection with LTIP
9th Oct 202311:45 amRNSExpansion and Further Extension of SWF Arrangement
27th Sep 20235:30 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSTransaction in Own Shares
26th Sep 20237:00 amRNSTransaction in Own Shares
25th Sep 20237:00 amRNSTransaction in Own Shares
22nd Sep 20237:00 amRNSTransaction in Own Shares
21st Sep 20237:00 amRNSTransaction in Own Shares
19th Sep 20231:30 pmRNSTransaction in Own Shares
13th Sep 202312:00 pmRNS2Q23 Results & Quarterly Report
11th Sep 20237:00 amRNSStatement on YPF Damages Ruling
8th Sep 20234:30 pmRNSSuspension - Burford Capital Limited
8th Sep 20234:09 pmRNSStatement re Petersen and Eton Park Matters
31st Aug 20232:00 pmRNSNotice of 2Q23 Results Call Details
25th Aug 20237:00 amRNSUS SEC Closes Comment Letter Review
9th Aug 20232:00 pmRNSDirector/PDMR Shareholding
12th Jul 202310:37 amRNSResult of AGM
7th Jul 202312:45 pmRNSPricing of Early Redemption of 2024 Bonds
4th Jul 20235:00 pmRNSTransaction in Own Shares
3rd Jul 20232:00 pmRNSCompletion of Share Purchases & PDMR Transactions
29th Jun 202311:14 amRNSIntended Purchases of Ordinary Shares
26th Jun 20236:00 pmRNSDirector/PDMR Shareholding
26th Jun 20232:08 pmRNSUpdate & Release Date for 2Q23 Results
26th Jun 20232:07 pmRNSNotice of Early Redemption of Bonds due 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.